FI991384A0 - Mycobacterium vaccae immuunijärjestelmän Th2-aktiivisuuden hillitsemiseksi - Google Patents

Mycobacterium vaccae immuunijärjestelmän Th2-aktiivisuuden hillitsemiseksi

Info

Publication number
FI991384A0
FI991384A0 FI991384A FI991384A FI991384A0 FI 991384 A0 FI991384 A0 FI 991384A0 FI 991384 A FI991384 A FI 991384A FI 991384 A FI991384 A FI 991384A FI 991384 A0 FI991384 A0 FI 991384A0
Authority
FI
Finland
Prior art keywords
activity
reducing
immune system
mycobacterium vaccae
vaccae
Prior art date
Application number
FI991384A
Other languages
English (en)
Swedish (sv)
Other versions
FI991384A (fi
FI120136B (fi
Inventor
Graham Arthur William Rook
John Lawson Stanford
Alimuddin Ismail Zumla
Original Assignee
Stanford Rook Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9626215.9A external-priority patent/GB9626215D0/en
Priority claimed from GBGB9626859.4A external-priority patent/GB9626859D0/en
Application filed by Stanford Rook Ltd filed Critical Stanford Rook Ltd
Publication of FI991384A publication Critical patent/FI991384A/fi
Publication of FI991384A0 publication Critical patent/FI991384A0/fi
Application granted granted Critical
Publication of FI120136B publication Critical patent/FI120136B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FI991384A 1996-12-18 1999-06-17 Mycobacterium vaccae immuunijärjestelmän Th2-aktiivisuuden hillitsemiseksi FI120136B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9626215 1996-12-18
GBGB9626215.9A GB9626215D0 (en) 1996-12-18 1996-12-18 A therapeutic agent and its use
GB9626859 1996-12-24
GBGB9626859.4A GB9626859D0 (en) 1996-12-24 1996-12-24 Medical treatment
GB9703460 1997-12-17
PCT/GB1997/003460 WO1998026790A1 (en) 1996-12-18 1997-12-17 Mycobacterium vaccae for down-regulation of the th2 activity of the immune system

Publications (3)

Publication Number Publication Date
FI991384A FI991384A (fi) 1999-06-17
FI991384A0 true FI991384A0 (fi) 1999-06-17
FI120136B FI120136B (fi) 2009-07-15

Family

ID=26310662

Family Applications (1)

Application Number Title Priority Date Filing Date
FI991384A FI120136B (fi) 1996-12-18 1999-06-17 Mycobacterium vaccae immuunijärjestelmän Th2-aktiivisuuden hillitsemiseksi

Country Status (18)

Country Link
EP (1) EP0951289B1 (fi)
JP (1) JP4358306B2 (fi)
KR (1) KR100533818B1 (fi)
CN (1) CN1129453C (fi)
AP (1) AP1044A (fi)
AT (1) ATE307600T1 (fi)
AU (1) AU730548B2 (fi)
BR (1) BR9713959A (fi)
CA (1) CA2273848C (fi)
DE (1) DE69734461T2 (fi)
DK (1) DK0951289T3 (fi)
ES (1) ES2251744T3 (fi)
FI (1) FI120136B (fi)
HK (1) HK1021316A1 (fi)
NO (1) NO321202B1 (fi)
NZ (1) NZ336147A (fi)
RU (1) RU2197989C2 (fi)
WO (1) WO1998026790A1 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6361776B1 (en) * 1999-12-06 2002-03-26 Genesis Research & Development Corp. Ltd. Compounds isolated from M. vaccae and their use in modulation of immune responses
WO2001097821A1 (en) * 2000-06-19 2001-12-27 Mucoprotec Pty Ltd Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor.
AUPR101600A0 (en) * 2000-10-25 2000-11-16 Atheromastat Pty Ltd Compositions and methods for diagnosis and treatment of cardiovascular disorders
DE60235971D1 (de) 2001-02-20 2010-05-27 Maruho Kk Neue medizinische verwendung von alpha-antigen oder alpha-antigen-gen
AU2016281765B2 (en) * 2015-06-24 2022-06-16 Immodulon Therapeutics Limited A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy
US11077179B2 (en) 2017-08-10 2021-08-03 Epicgenetics, Inc. Method for treating fibromyalgia and chronic fatigue syndrome

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
ATE154759T1 (de) * 1990-11-08 1997-07-15 Univ London Mycobacterium als adjuvans für antigene
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions
GB9406301D0 (en) * 1994-03-30 1994-05-25 Univ London Immunotherapeutic agent and its use
AUPM864894A0 (en) * 1994-10-07 1994-11-03 Borody, Thomas Julius Treatment of bowel-dependent neurological disorders

Also Published As

Publication number Publication date
CA2273848C (en) 2008-02-19
DE69734461D1 (de) 2005-12-01
KR100533818B1 (ko) 2005-12-07
FI991384A (fi) 1999-06-17
AP1044A (en) 2002-02-18
CN1129453C (zh) 2003-12-03
DK0951289T3 (da) 2006-03-13
CA2273848A1 (en) 1998-06-25
WO1998026790A1 (en) 1998-06-25
AU730548B2 (en) 2001-03-08
ES2251744T3 (es) 2006-05-01
ATE307600T1 (de) 2005-11-15
CN1246056A (zh) 2000-03-01
AU7735598A (en) 1998-07-15
JP4358306B2 (ja) 2009-11-04
JP2001506256A (ja) 2001-05-15
RU2197989C2 (ru) 2003-02-10
KR20000069518A (ko) 2000-11-25
DE69734461T2 (de) 2006-07-06
EP0951289A1 (en) 1999-10-27
HK1021316A1 (en) 2000-06-09
BR9713959A (pt) 2000-04-11
EP0951289B1 (en) 2005-10-26
NO321202B1 (no) 2006-04-03
NO992957D0 (no) 1999-06-17
NZ336147A (en) 2001-03-30
FI120136B (fi) 2009-07-15
NO992957L (no) 1999-08-10
AP9901553A0 (en) 1999-06-30

Similar Documents

Publication Publication Date Title
DE3689035D1 (de) Rauschminderungssystem.
DE69319783D1 (de) Geräuschminderungssystem
BR9305202A (pt) Sistema de propulsão elétrica.
IL107864A0 (en) Bearing assembly monitoring system
DE19580298T1 (de) Apherese-System
AU1597795A (en) Method of enhancing the human immune system
DE69130452D1 (de) Rauschunterdrückungssystem
IL84948A0 (en) Noise reduction system
FI99109B (fi) Varavoimajärjestelmä
DE69321268D1 (de) Personenlokalisationssystem
NL194019B (nl) Foto-elektrisch omzettingssysteem.
NL193046B (nl) Stelsel voor het omzetten van geluid.
FI864239A0 (fi) System i luftfarkoster foer varning foer markytans naerhet med periferimodifikation baserad pao landningshastigheten.
KR930702893A (ko) 상보시스템을 저해하거나 또는 면역활성을 억제하는 성분물
DE69717082D1 (de) Sicherheitsgurtsystem
KR950700483A (ko) 베어링 세정 시스템
FI863720A (fi) System foer utval av faner baserad pao deras storlek.
FI991384A (fi) Mycobacterium vaccae immuunijärjestelmän Th2-aktiivisuuden hillitsemiseksi
DE3668950D1 (de) Ringbefestigungsanlage.
EP0606501A4 (en) CURRENT REGENERATION SYSTEM.
EP0648124A4 (en) METHOD FOR STIMULATING THE IMMUNE SYSTEM.
AU591302B2 (en) Wheel chair ramp system
HUP0001602A3 (en) Mycobacterium vaccae for down-regulation of the th2 activity of the immune system
ATA76192A (de) Solaranlage
ES2014480B3 (es) Sub-unidad de motor de freno.

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120136

Country of ref document: FI

MM Patent lapsed